Acceleron Pharma Overview

Acceleron Pharma Gross Profit

Gross Profit analysis for XLRN.

Quarterly Gross Profit

$34.20M

↑ 51.58% YoY

As of Sep 30, 2021

Annual Gross Profit (TTM)

$112.76M

↑ 6.38% YoY

Trailing 12 months ending Sep 30, 2021

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin